T1	Participants 42 93	secondary hyperparathyroidism in stages 3 and 4 CKD
T2	Participants 260 311	patients with chronic kidney disease (CKD) stage 5.
T3	Participants 512 555	patients with stages 3 and 4 CKD with SHPT.
T4	Participants 1243 1283	Two hundred twenty patients participated